Navigation Links
Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Date:10/26/2008

796, Paratek is also developing other broad- and narrow-spectrum tetracycline antibiotics to treat hospital and community infections based on its novel tetracycline chemistry expertise.

Outside of its tetracycline antibacterial program, Paratek has also identified small molecules that inhibit bacteria-specific transcription factors for Multiple Adaptational Response (MAR) genes which control bacterial virulence and resistance development.

Based upon a growing body of clinical research and as part of its effort to exploit its novel tetracycline derivatives and their unique mechanism of action in selected inflammatory and neurodegenerative conditions, Paratek has an active chemical synthesis effort to produce novel and diverse small molecules, with the goal of developing nonantibacterial compounds with improved activity in serious inflammatory and neurodegenerative diseases. In addition, Paratek is encouraged by early evidence of the ability of tetracycline derivatives to affect mRNA splicing, as in spinal muscular atrophy (SMA), which may also have activity in related orphan genetic disorders, such as cystic fibrosis and Duchenne Muscular Dystrophy.

Paratek has active collaborations with Merck & Co., MerckSerono, Warner Chilcott and FSMA to develop tetracycline-derived small molecule drugs for a range of uses, including community-acquired bacterial infections, multiple sclerosis (MS), acne & rosacea, and SMA. Paratek is privately held and headquartered in Boston, Massachusetts, U.S. For more information about Paratek and its research and development initiatives, visit Paratek's website at http://www.paratekpharm.com.


'/>"/>
SOURCE Paratek Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
2. Paratek Pharmaceuticals Announces the Close of $40 Million Private Placement to Finance Programs to Combat MRSA Infections
3. Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)...  PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results ... June 30, 2014. Quarter Ended June ... 30, 2014 increased $492,000, or 18%, to $3.2 million ... 30, 2013, due primarily to an increase of $746,000 ... Company,s largest customer, partially offset by an aggregate decrease ...
(Date:9/18/2014)... Sept. 18, 2014  Casen Buswell has a rare vascular ... harden.  His case is one of only 14 known cases ... only hospital in the United States , ... treatment with the dual wave-length laser, is Methodist Children,s Hospital, ... . Using a laser available in South ...
(Date:9/18/2014)... LONDON , Sept. 18, 2014 ... for innovation, increasing clinical development costs, new technologies ... fast-changing environment are important factors driving industry change. ... trial costs continue to rise due to a ... conducted by industry think tanks suggest each day ...
Breaking Medicine Technology:Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 2Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 3Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 4Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 5Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 6Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 7Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 8Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 9Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 10Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 11Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 12Pro-Dex, Inc. Announces Fiscal 2014 Fourth Quarter And Full-Year Results 13Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3
... Generex Biotechnology Corporation ( www.generex.com ) (OTC Bulletin ... peer-reviewed scientific journal Diabetes, Obesity and Metabolism ... Oral-lyn™, the Company,s proprietary buccal insulin spray product. ... subjects with impaired glucose tolerance: the prevoral study , ...
... Bionovo, Inc. (Nasdaq: BNVI ), a pharmaceutical company ... women,s health and cancer, today announced that it had received ... Clinical Guidance meeting that took place on November 8, 2010. ... overall clinical development plan. "We had a ...
Cached Medicine Technology:Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 2Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 3Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 4Generex Announces Publication of New Positive Generex Oral-lyn™ Data in Peer-Reviewed Journal 5Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 2Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 3Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 4
(Date:9/19/2014)... 19, 2014 Ticket Down is ... for his 2014 concert tour. Concertgoers can add promo/coupon ... there are a handful of artists that are considered royalty. ... Saginaw, MichIgan, Wonder has been a force in the music ... the music business, he has released 23 studio albums, three ...
(Date:9/19/2014)... 2014 Business Insider Australia Rates Appy ... Earlier this month Appy Pie was also listed as one ... App Developer' by Yahoo . , Appy Pie a leading ... beautiful applications within minutes and it requires no coding knowledge ... support for latest mobile operating systems, the apps created using ...
(Date:9/19/2014)... Dr. John Paul Gallardo and Dr. William P. ... practice. Routinely at the forefront of cutting-edge oral ... one of the first dentistry teams in the country ... treating periodontal disease. , Periodontal disease ... in the world. The United State’s Surgeon General’s ...
(Date:9/19/2014)... Kyrgyzstan has one of the highest ... the burden of tuberculosis (TB) and address the ... Abt Associates has been awarded the U.S. Agency ... a five-year cooperative agreement with total funding of ... and equitable access to high-quality TB services for ...
(Date:9/19/2014)... Steven Reinberg HealthDay Reporter ... half of all Americans got a flu shot last year, ... months and older get vaccinated for the coming flu season. ... getting the protection from flu they could get," said Dr. ... and Prevention, during a morning news conference. The result ...
Breaking Medicine News(10 mins):Health News:Stevie Wonder Tickets: Ticket Down Slashes Ticket Prices in Seattle, Boston, New York, Atlanta, Chicago, Detroit, Philadelphia, Toronto, Las Vegas & Oakland 2Health News:Stevie Wonder Tickets: Ticket Down Slashes Ticket Prices in Seattle, Boston, New York, Atlanta, Chicago, Detroit, Philadelphia, Toronto, Las Vegas & Oakland 3Health News:Business Insider Australia Rates Appy Pie as a top App & Game Building Platform 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 2Health News:Gallardo & Lamas Periodontics & Implant Dentistry Therapeutic Periodontal Treatment Shown to Improve Patient’s Overall Health 3Health News:New Project Aims to Reduce Burden of Tuberculosis in the Kyrgyz Republic 2Health News:Almost Everyone Needs a Flu Shot: CDC 2Health News:Almost Everyone Needs a Flu Shot: CDC 3
... their advice can have, experts say , WEDNESDAY, Jan. 9 ... about drinking may help at least one in six problem ... a new data review finds. , The systematic review of ... the American Journal of Preventive Medicine . , ...
... screening for cardiovascular problems , , WEDNESDAY, Jan. 9 (HealthDay ... heartbeat pattern in young athletes that makes some of ... , The report comes amid intense debate in the ... said Dr. Mark S. Link, director of the Tufts-New ...
... pieces of ribonucleic acid (RNA) that suppress the spread ... new research shows that the most invasive and aggressive ... molecules. When the researchers put those molecules back into ... their ability to spread., The tiny RNAs prevent the ...
... since you made that New Years resolution to exercise more, but ... , You know all the benefits of a healthy lifestyle: ... exercise has been linked to reduced depressive symptoms and reduced risk ... and watching TV instead of going for a short jog is ...
... HealthCentral,Network, Inc. (http://www.HealthCentral.com ) today announced ... joining the,StopSmokingConnection.com community as an expert. Martin, ... Your Battle Over Shortness of Breath and,web ... write,primarily about Chronic Obstructive Pulmonary Disease (COPD)., ...
... Texas Mutual Insurance Company, an,aggressive tort reform advocate in ... litigation in which the insurance company tried,to overturn an ... a workplace injury,a Dallas state district judge ruled today., ... medical record,Texas Mutual had no evidence to continue to ...
Cached Medicine News:Health News:Short Chat With Doc Can Curb Problem Drinking 2Health News:Test Finds Rare Heart Defect in Some Young Athletes 2Health News:Test Finds Rare Heart Defect in Some Young Athletes 3Health News:Small RNAs can prevent spread of breast cancer 2Health News:Small RNAs can prevent spread of breast cancer 3Health News:Small RNAs can prevent spread of breast cancer 4Health News:Exercising judgment: The psychology of fitness 2Health News:Exercising judgment: The psychology of fitness 3Health News:Exercising judgment: The psychology of fitness 4Health News:Exercising judgment: The psychology of fitness 5Health News:Exercising judgment: The psychology of fitness 6Health News:Exercising judgment: The psychology of fitness 7Health News:Exercising judgment: The psychology of fitness 8Health News:Exercising judgment: The psychology of fitness 9Health News:Exercising judgment: The psychology of fitness 10Health News:Prominent Respiratory Therapist and Author Joins StopSmokingConnection.com as a COPD Expert 2Health News:Judge Rules Texas Mutual Insurance Co. Committed Litigation Fraud With Falsified Document, According to Doyle Raizner LLP 2
... The Akbarnia PDR Instruments ... surgeons negotiate in and around ... and reconstruction procedures. The instruments ... construction, a variety of angled ...
... is a point-of-care system designed for the ... to as Platelet Rich Plasma - PRP) ... small sample of blood. The Symphony II ... which are found in the platelets. The ...
... the introduction of the Leica Dual Imaging Color ... latest available information technology. All important and necessary ... Leica M520 / M500 N optical platform on ... a huge amount of benefits: highest brightness, contrast ...
... Headlight mounted micro video camera has been ... in areas otherwise invisible to all but ... The system may be used for all ... crowding of the sterile area and enabling ...
Medicine Products: